Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE
- PMID: 26002293
- DOI: 10.1053/j.ajkd.2015.04.011
Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE
Abstract
Background: A recent study showed an increased risk of death in African Americans compared with whites with end-stage renal disease (ESRD) due to lupus nephritis (LN). We assessed the impact of age stratification, socioeconomic factors, and kidney transplantation on the disparity in patient survival among African American versus non-African American patients with LN-caused ESRD, compared with other causes.
Study design: Retrospective cohort study.
Setting & participants: Using the US Renal Data System database, we identified 12,352 patients with LN-caused ESRD among 1,132,202 patients who initiated maintenance dialysis therapy from January 1, 1995, through December 31, 2006, and were followed up until December 31, 2010.
Predictors: Baseline demographics and comorbid conditions, Hispanic ethnicity, socioeconomic factors (employment status, Medicare/Medicaid insurance, and area-level median household income based on zip code as obtained from the 2000 US census), and kidney transplantation as a time-dependent variable.
Outcome: All-cause mortality.
Measurements: Multivariable Cox and competing-risk regressions.
Results: Mean duration of follow-up in the LN-caused ESRD and other-cause ESRD cohorts were 6.24±4.20 (SD) and 4.06±3.61 years, respectively. 6,106 patients with LN-caused ESRD (49.43%) and 853,762 patients with other-cause ESRD (76.24%) died during the study period (P<0.001). Patients with LN-caused ESRD were significantly younger (mean age, 39.92 years) and more likely women (81.65%) and African American (48.13%) than those with other-cause ESRD. In the fully adjusted multivariable Cox regression model, African American (vs non-African American) patients with LN-caused ESRD had significantly increased risk of death at age 18 to 30 years (adjusted HR, 1.43; 95% CI, 1.24-1.65) and at age 31 to 40 years (adjusted HR, 1.17; 95% CI, 1.02-1.34). Among patients with other-cause ESRD, African Americans were at significantly increased risk at age 18 to 30 years (adjusted HR, 1.17; 95% CI, 1.11-1.22).
Limitations: We used zip code-based median household income as a surrogate for patient income. Residual socioeconomic confounders may exist.
Conclusions: African Americans are at significantly increased risk of death compared with non-African Americans with LN-caused ESRD at age 18 to 40 years, a racial disparity risk that is 10 years longer than that in the general ESRD population. Accounting for area-level median household income and transplantation significantly attenuated the disparity in mortality of African American versus non-African American patients with LN-caused ESRD.
Keywords: African American; Racial disparity; US Renal Data System (USRDS); all-cause mortality; competing risk; dialysis; end-stage renal disease (ESRD); kidney transplantation; lupus nephritis; survival disparity; systemic lupus erythematosus (SLE).
Published by Elsevier Inc.
Similar articles
-
Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis.Arthritis Care Res (Hoboken). 2015 Oct;67(10):1453-62. doi: 10.1002/acr.22562. Arthritis Care Res (Hoboken). 2015. PMID: 25624071 Free PMC article.
-
Racial differences and income disparities are associated with poor outcomes in kidney transplant recipients with lupus nephritis.Transplantation. 2013 Jun 27;95(12):1471-8. doi: 10.1097/TP.0b013e318292520e. Transplantation. 2013. PMID: 23680929
-
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.Arthritis Care Res (Hoboken). 2011 Dec;63(12):1642-53. doi: 10.1002/acr.20607. Arthritis Care Res (Hoboken). 2011. PMID: 22058067 Free PMC article.
-
ESKD, Transplantation, and Dialysis in Lupus Nephritis.Semin Nephrol. 2015 Sep;35(5):500-8. doi: 10.1016/j.semnephrol.2015.08.011. Semin Nephrol. 2015. PMID: 26573552 Review.
-
Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation.BMC Nephrol. 2020 May 1;21(1):156. doi: 10.1186/s12882-020-01811-y. BMC Nephrol. 2020. PMID: 32357924 Free PMC article.
Cited by
-
Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.Lupus. 2017 Feb;26(2):186-194. doi: 10.1177/0961203316660625. Epub 2016 Aug 19. Lupus. 2017. PMID: 27488473 Free PMC article.
-
The global burden of SLE: prevalence, health disparities and socioeconomic impact.Nat Rev Rheumatol. 2016 Oct;12(10):605-20. doi: 10.1038/nrrheum.2016.137. Epub 2016 Aug 25. Nat Rev Rheumatol. 2016. PMID: 27558659 Review.
-
Engaging African ancestry participants in SLE clinical trials.Lupus Sci Med. 2018 Dec 11;5(1):e000297. doi: 10.1136/lupus-2018-000297. eCollection 2018. Lupus Sci Med. 2018. PMID: 30613420 Free PMC article.
-
Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis.Clin Kidney J. 2018 Apr;11(2):207-218. doi: 10.1093/ckj/sfx093. Epub 2017 Aug 31. Clin Kidney J. 2018. PMID: 29644061 Free PMC article.
-
Depressive Symptoms Are Associated With Low Treatment Adherence in African American Individuals With Systemic Lupus Erythematosus.J Clin Rheumatol. 2018 Oct;24(7):368-374. doi: 10.1097/RHU.0000000000000794. J Clin Rheumatol. 2018. PMID: 29912774 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical